{
    "organizations": [],
    "uuid": "63a75d06f4d4b91e9fc116c670d784e4d0991297",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-portola-pharmaceuticals-receives-1/brief-portola-pharmaceuticals-receives-100-mln-milestone-payment-from-healthcare-royalty-partners-for-fda-approval-of-andexxa-idUSASC0A3KD",
    "ord_in_thread": 0,
    "title": "BRIEF-Portola Pharmaceuticals Receives $100 Mln Milestone Payment From Healthcare Royalty Partners For FDA Approval Of Andexxa",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 24 (Reuters) - Portola Pharmaceuticals Inc:\n* PORTOLA PHARMACEUTICALS RECEIVES $100 MILLION MILESTONE PAYMENT FROM HEALTHCARE ROYALTY PARTNERS FOR FDA APPROVAL OF ANDEXXAÂ® Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-24T20:38:00.000+03:00",
    "crawled": "2018-05-25T16:08:52.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "portola",
        "pharmaceutical",
        "inc",
        "portola",
        "pharmaceutical",
        "receives",
        "million",
        "milestone",
        "payment",
        "healthcare",
        "royalty",
        "partner",
        "fda",
        "approval",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}